Usefulness of novel potassium adsorbents

JRCT ID: jRCT1021210015

Registered date:30/06/2021

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Chronic kidney disease, hyperkalemia
• Date of first enrollment: 03/08/2021
• Target sample size: 50
• Study type: Observational

Outcome(s)

• Primary Outcome: Compliance rate of SZC

Secondary Outcome

Characteristics of SZC (easy to drink, taste, texture, portability)
Constipation score
Changes in defecation status
Total number of drugs administered
Serum potassium, calcium, magnesium values
Presence or absence of electrocardiogram change
Blood pressure, pulse rate
Presence or absence of other hyperkalemia treatments
Patient Satisfaction with SZC

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Chronic kidney disease patients with hyperkalemia (serum potassium 5.1 mEq / L or higher) or who have already taken potassium adsorbents who have given written consent to this task are eligible.
• Exclude criteria: none

Related Information

• Primary Sponsor: Fujita Takeshi